GlassScriptPhysician profile
Xiangli Li
NPI 1851657001
$9,226.89
in general payments reported to CMS, 2019-2025
52 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $791 · 2021: $1,478 · 2022: $1,589 · 2023: $1,238 · 2024: $1,167 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,113.18 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,106.11 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $854.51 | 2019-2025 | Evenity, Repatha, Prolia |
| Lilly USA, LLC | $758.52 | 2019-2025 | Zepbound, Mounjaro, Kisunla |
| Pfizer INC. | $511.85 | 2019-2025 | |
| Novo Nordisk INC | $510.99 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $450.76 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $372.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $329.97 | 2020-2025 | Xarelto, Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $295.32 | 2022-2025 | |
| Boston Scientific Corporation | $238.09 | 2024-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Merck Sharp & Dohme LLC | $196.45 | 2019-2025 | Dificid, Gardasil 9, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $178.71 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Astellas Pharma US INC | $177.01 | 2019-2024 | Veozah |
| Otsuka America Pharmaceutical, INC. | $152.78 | 2023-2025 | Rexulti |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $152.64 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $144.53 | 2021-2022 | |
| Si-Bone, INC. | $122.01 | 2019-2025 | |
| Abbott Laboratories | $112.25 | 2020-2023 | Octrode, Mitraclip |
| Biohaven Pharmaceutical Holding Company LTD. | $110.98 | 2022 | |
| Seqirus USA INC | $109.70 | 2021-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Edwards Lifesciences Corporation | $83.92 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lundbeck LLC | $78.53 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $72.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.73 | 2020-2024 | Tradjenta, Jardiance |
| Mannkind Corporation | $66.72 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $61.89 | 2019-2022 | |
| Linus Health, INC. | $55.43 | 2022 | |
| Radius Health, INC. | $51.12 | 2020-2024 | Tymlos |
| Tactile Systems Technology INC | $50.92 | 2021-2022 | |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Electromed, INC. | $48.37 | 2022-2023 | Smartvest |
| Sanofi Pasteur INC. | $47.31 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $41.81 | 2021-2022 | |
| Abiomed | $40.78 | 2024 | Impella |
| Nevro Corp. | $39.89 | 2022 | |
| Arbor Pharmaceuticals, INC. | $38.02 | 2021 | |
| Corcept Therapeutics | $37.25 | 2025 | Korlym |
| Amarin Pharma, INC. | $35.75 | 2020-2021 | |
| Madrigal Pharmaceuticals | $30.51 | 2025 | Rezdiffra |
| Dexcom, INC. | $25.07 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.43 | 2021 | |
| Sumitomo Pharma America, INC. | $23.42 | 2024 | Gemtesa |
| Smith+Nephew, INC. | $22.66 | 2025 | Collagenase Santyl |
| Ibsa Pharma INC. | $20.79 | 2021 | |
| Genentech USA, INC. | $19.51 | 2020 | |
| Philips North America LLC | $19.04 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $17.51 | 2020 | |
| Neotract INC. | $16.21 | 2019 | |
| Lucid Diagnostics INC. | $15.20 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2025 | Zoryve |
| Cequr Corporation | $7.71 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiangli Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.